Unjha Formulations files FY26 annual results with BSE
- Unjha Formulations filed FY26 audited results with BSE on September 8, 2026
- Financial statements cover the period ending March 31, 2026
- AGM was held on August 14, 2026 to approve the accounts
- No specific revenue or profit figures disclosed in this notice

*this image is generated using AI for illustrative purposes only.
Unjha Formulations submitted its audited financial statements for FY26 to the Bombay Stock Exchange on September 8, 2026. The filing includes the balance sheet, profit and loss account, and cash flow statement as of March 31, 2026.
The submission was made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company held its Annual General Meeting on August 14, 2026, where these results were approved by shareholders.
Filing Details
Krutibhai Mayank Patel, Managing Director of Unjha Formulations, signed the submission letter. The document references scrip code 531762 and confirms that the XML file containing the financial data has been uploaded via the BSE listing portal.
No specific financial metrics such as revenue, net profit, or dividend declarations were disclosed in this particular regulatory communication. The filing serves primarily as a procedural notification of the availability of the full financial statements.
Historical Stock Returns for Unjha Formulations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | +23.16% | +39.26% | +66.35% | +37.72% | +273.15% |
How are Unjha Formulations' FY26 revenue and net profit margins expected to compare with FY25 given the current competitive landscape in the dermatology and hair care segments?
Will the company announce any dividend payouts or share buyback plans in the upcoming investor presentations following the AGM?
What strategic initiatives is Unjha Formulations prioritizing for international expansion in key markets like the US and Europe for the next fiscal year?


































